Royal Marsden NHS Foundation Trust: Immunotherapy Drug Pembrolizumab Available for Use on the NHS for Locally Advanced Cervical Cancers
June 26, 2026
June 26, 2026
LONDON, England, June 26 -- The Royal Marsden National Health Service Foundation Trust issued the following news:
* * *
Immunotherapy drug pembrolizumab available for use on the NHS for locally advanced cervical cancers
The approval follows a recommendation by the National Institute for Health and Social Care Excellence (NICE).
-
The Royal Marsden welcomes the decision to make the immunotherapy drug pembrolizumab available for use . . .
* * *
Immunotherapy drug pembrolizumab available for use on the NHS for locally advanced cervical cancers
The approval follows a recommendation by the National Institute for Health and Social Care Excellence (NICE).
-
The Royal Marsden welcomes the decision to make the immunotherapy drug pembrolizumab available for use . . .